Stoke Therapeutics Inc (STOK) Stock Price, Quote & News

Company Profile

Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, engages in the development of treatments for severe genetic diseases by upregulating protein expression. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output (TANGO) approach in developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its lead product candidates include STK-002, which is in preclinical stage for the treatment of autosomal dominant optic atrophy; and Zorevun...

Industry: Biotechnology

Sector: Healthcare

Phone: 781 430 8200

Website: www.stoketherapeutics.com

Address:

45 Wiggins Avenue, Bedford, United States

Christyatmond Oct. 3 at 2:33 PM

$STOK have this since May, never once worry about it. Every week is a good week.

0 · Reply

highnihilism Sep. 30 at 11:34 AM

$DENN Denny's: 32 trades, $32K vs $44K avg (0.73x). $21K calls / $12K puts. $QQQE Direxion Nasdaq 100 Equal Weighted ETF: 2 trades, $21K vs $7K avg (2.81x !!). $21K calls / $0 puts. $APPN Appian: 50 trades, $34K vs $251K avg (0.13x !!). $21K calls / $13K puts. $STOK Stoke Therapeutics: 26 trades, $25K vs $121K avg (0.21x). $21K calls / $5K puts.

0 · Reply

SweepCastApp Sep. 29 at 1:14 PM

$STOK: Unusual Options Activity Alerted CALL flow observed 100x contracts at Strike price of $25 Exp on 11/21/2025 with Premium of $33K and showing BULLISH Sentiment

0 · Reply